CytomX Therapeutics, Inc.
CTMXNasdaqCIK 1501989HealthcareFiscal year ends Dec 31
Income statement
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $m | 26.4Revenue, Q3 FY2023, three months to 2023-09-30$26.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | 26.6Revenue, Q4 FY2023, three months to 2023-12-31$26.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-06, accession 0000950170-25-034575. Derived: 12-month figure less the 9-month figure.Report this figure | 41.5Revenue, Q1 FY2024, three months to 2024-03-31$41.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | 25.1Revenue, Q2 FY2024, three months to 2024-06-30$25.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0000950170-25-104991.Report this figure | 33.4Revenue, Q3 FY2024, three months to 2024-09-30$33.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 38.1Revenue, Q4 FY2024, three months to 2024-12-31$38.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 50.9Revenue, Q1 FY2025, three months to 2025-03-31$50.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 18.7Revenue, Q2 FY2025, three months to 2025-06-30$18.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 6.0Revenue, Q3 FY2025, three months to 2025-09-30$6.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 0.7Revenue, Q4 FY2025, three months to 2025-12-31$663.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 10.3Revenue, Q1 FY2026, three months to 2026-03-31$10.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 1.4Revenue, Q2 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Research and development | $m | 16.4Research and development, Q3 FY2023, three months to 2023-09-30$16.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | 19.4Research and development, Q4 FY2023, three months to 2023-12-31$19.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-06, accession 0000950170-25-034575. Derived: 12-month figure less the 9-month figure.Report this figure | 22.1Research and development, Q1 FY2024, three months to 2024-03-31$22.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | 25.2Research and development, Q2 FY2024, three months to 2024-06-30$25.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0000950170-25-104991.Report this figure | 21.4Research and development, Q3 FY2024, three months to 2024-09-30$21.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 14.8Research and development, Q4 FY2024, three months to 2024-12-31$14.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 18.9Research and development, Q1 FY2025, three months to 2025-03-31$18.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 13.3Research and development, Q2 FY2025, three months to 2025-06-30$13.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 15.3Research and development, Q3 FY2025, three months to 2025-09-30$15.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 21.2Research and development, Q4 FY2025, three months to 2025-12-31$21.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 19.2Research and development, Q1 FY2026, three months to 2026-03-31$19.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 17.6Research and development, Q2 FY2026, three months to 2026-06-30$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Operating income | $m | 3.1Operating income, Q3 FY2023, three months to 2023-09-30$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | (0.6)Operating income, Q4 FY2023, three months to 2023-12-31−$606.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034575. Derived: 12-month figure less the 9-month figure.Report this figure | 11.7Operating income, Q1 FY2024, three months to 2024-03-31$11.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | (8.5)Operating income, Q2 FY2024, three months to 2024-06-30−$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0000950170-25-104991.Report this figure | 4.1Operating income, Q3 FY2024, three months to 2024-09-30$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 17.7Operating income, Q4 FY2024, three months to 2024-12-31$17.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 22.6Operating income, Q1 FY2025, three months to 2025-03-31$22.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | (1.3)Operating income, Q2 FY2025, three months to 2025-06-30−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | (15.8)Operating income, Q3 FY2025, three months to 2025-09-30−$15.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | (27.9)Operating income, Q4 FY2025, three months to 2025-12-31−$27.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | (19.7)Operating income, Q1 FY2026, three months to 2026-03-31−$19.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | (23.8)Operating income, Q2 FY2026, three months to 2026-06-30−$23.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | 2.8Income tax, Q3 FY2023, three months to 2023-09-30$2.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | 1.1Income tax, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-06, accession 0000950170-25-034575. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Income tax, Q1 FY2024, three months to 2024-03-31$49.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | 0.1Income tax, Q2 FY2024, three months to 2024-06-30$51.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0000950170-25-104991.Report this figure | 0.1Income tax, Q3 FY2024, three months to 2024-09-30$61.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 0.1Income tax, Q4 FY2024, three months to 2024-12-31$62.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 0.1Income tax, Q1 FY2025, three months to 2025-03-31$62.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 0.1Income tax, Q2 FY2025, three months to 2025-06-30$63.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 0.1Income tax, Q3 FY2025, three months to 2025-09-30$58.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 0.1Income tax, Q4 FY2025, three months to 2025-12-31$54.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 0.1Income tax, Q1 FY2026, three months to 2026-03-31$59.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 0.1Income tax, Q2 FY2026, three months to 2026-06-30$60.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Net income | $m | 3.0Net income, Q3 FY2023, three months to 2023-09-30$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | 0.8Net income, Q4 FY2023, three months to 2023-12-31$837.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-06, accession 0000950170-25-034575. Derived: 12-month figure less the 9-month figure.Report this figure | 13.8Net income, Q1 FY2024, three months to 2024-03-31$13.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | (6.5)Net income, Q2 FY2024, three months to 2024-06-30−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 5.7Net income, Q3 FY2024, three months to 2024-09-30$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 18.9Net income, Q4 FY2024, three months to 2024-12-31$18.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 23.5Net income, Q1 FY2025, three months to 2025-03-31$23.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | (0.2)Net income, Q2 FY2025, three months to 2025-06-30−$154.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | (14.2)Net income, Q3 FY2025, three months to 2025-09-30−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | (26.5)Net income, Q4 FY2025, three months to 2025-12-31−$26.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | (18.2)Net income, Q1 FY2026, three months to 2026-03-31−$18.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | (20.7)Net income, Q2 FY2026, three months to 2026-06-30−$20.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
Balance sheet
| Line item | Unit | Q3 FY20232023-09-30 | FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $m | 26.0Cash and equivalents, Q3 FY2023, at 2023-09-30$26.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0000950170-23-060201.Report this figure | 17.2Cash and equivalents, FY2023, at 2023-12-31$17.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-06, accession 0000950170-25-034575.Report this figure | 36.2Cash and equivalents, Q1 FY2024, at 2024-03-31$36.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0000950170-24-055588.Report this figure | 43.2Cash and equivalents, Q2 FY2024, at 2024-06-30$43.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-093865.Report this figure | 40.6Cash and equivalents, Q3 FY2024, at 2024-09-30$40.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | 38.1Cash and equivalents, FY2024, at 2024-12-31$38.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001193125-26-107146.Report this figure | 47.6Cash and equivalents, Q1 FY2025, at 2025-03-31$47.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | 49.0Cash and equivalents, Q2 FY2025, at 2025-06-30$49.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0000950170-25-104991.Report this figure | 34.2Cash and equivalents, Q3 FY2025, at 2025-09-30$34.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 12.7Cash and equivalents, FY2025, at 2025-12-31$12.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 28.8Cash and equivalents, Q1 FY2026, at 2026-03-31$28.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 17.2Cash and equivalents, Q2 FY2026, at 2026-06-30$17.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Current assets | $m | 201Current assets, Q3 FY2023, at 2023-09-30$201.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060201.Report this figure | 183Current assets, FY2023, at 2023-12-31$182.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034575.Report this figure | 167Current assets, Q1 FY2024, at 2024-03-31$167.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055588.Report this figure | 143Current assets, Q2 FY2024, at 2024-06-30$143.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093865.Report this figure | 124Current assets, Q3 FY2024, at 2024-09-30$124.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | 107Current assets, FY2024, at 2024-12-31$107.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001193125-26-107146.Report this figure | 86.6Current assets, Q1 FY2025, at 2025-03-31$86.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | 165Current assets, Q2 FY2025, at 2025-06-30$164.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104991.Report this figure | 149Current assets, Q3 FY2025, at 2025-09-30$149.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 144Current assets, FY2025, at 2025-12-31$143.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 353Current assets, Q1 FY2026, at 2026-03-31$353.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 373Current assets, Q2 FY2026, at 2026-06-30$373.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Total assets | $m | 221Total assets, Q3 FY2023, at 2023-09-30$221.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-060201.Report this figure | 202Total assets, FY2023, at 2023-12-31$201.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-06, accession 0000950170-25-034575.Report this figure | 185Total assets, Q1 FY2024, at 2024-03-31$184.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0000950170-24-055588.Report this figure | 159Total assets, Q2 FY2024, at 2024-06-30$159.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-093865.Report this figure | 139Total assets, Q3 FY2024, at 2024-09-30$139.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | 121Total assets, FY2024, at 2024-12-31$120.5m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001193125-26-107146.Report this figure | 98.5Total assets, Q1 FY2025, at 2025-03-31$98.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | 175Total assets, Q2 FY2025, at 2025-06-30$175.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0000950170-25-104991.Report this figure | 158Total assets, Q3 FY2025, at 2025-09-30$158.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 152Total assets, FY2025, at 2025-12-31$151.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 359Total assets, Q1 FY2026, at 2026-03-31$359.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 381Total assets, Q2 FY2026, at 2026-06-30$381.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Current liabilities | $m | 147Current liabilities, Q3 FY2023, at 2023-09-30$146.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060201.Report this figure | 156Current liabilities, FY2023, at 2023-12-31$155.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-06, accession 0000950170-25-034575.Report this figure | 145Current liabilities, Q1 FY2024, at 2024-03-31$144.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0000950170-24-055588.Report this figure | 143Current liabilities, Q2 FY2024, at 2024-06-30$142.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-093865.Report this figure | 119Current liabilities, Q3 FY2024, at 2024-09-30$119.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | 85.8Current liabilities, FY2024, at 2024-12-31$85.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001193125-26-107146.Report this figure | 50.2Current liabilities, Q1 FY2025, at 2025-03-31$50.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | 39.2Current liabilities, Q2 FY2025, at 2025-06-30$39.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0000950170-25-104991.Report this figure | 41.0Current liabilities, Q3 FY2025, at 2025-09-30$41.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 46.6Current liabilities, FY2025, at 2025-12-31$46.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 34.0Current liabilities, Q1 FY2026, at 2026-03-31$34.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 39.9Current liabilities, Q2 FY2026, at 2026-06-30$39.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Total liabilities | $m | 272Total liabilities, Q3 FY2023, at 2023-09-30$272.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-060201.Report this figure | 249Total liabilities, FY2023, at 2023-12-31$249.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-06, accession 0000950170-25-034575.Report this figure | 216Total liabilities, Q1 FY2024, at 2024-03-31$216.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-08, accession 0000950170-24-055588.Report this figure | 190Total liabilities, Q2 FY2024, at 2024-06-30$190.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-093865.Report this figure | 162Total liabilities, Q3 FY2024, at 2024-09-30$162.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | 121Total liabilities, FY2024, at 2024-12-31$121.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001193125-26-107146.Report this figure | 73.4Total liabilities, Q1 FY2025, at 2025-03-31$73.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | 55.1Total liabilities, Q2 FY2025, at 2025-06-30$55.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0000950170-25-104991.Report this figure | 50.9Total liabilities, Q3 FY2025, at 2025-09-30$50.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 52.6Total liabilities, FY2025, at 2025-12-31$52.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 39.4Total liabilities, Q1 FY2026, at 2026-03-31$39.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 79.2Total liabilities, Q2 FY2026, at 2026-06-30$79.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | (51.2)Shareholders' equity, Q3 FY2023, at 2023-09-30−$51.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123249.Report this figure | (47.4)Shareholders' equity, FY2023, at 2023-12-31−$47.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001193125-26-107146.Report this figure | (31.7)Shareholders' equity, Q1 FY2024, at 2024-03-31−$31.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | (31.2)Shareholders' equity, Q2 FY2024, at 2024-06-30−$31.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | (23.5)Shareholders' equity, Q3 FY2024, at 2024-09-30−$23.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | (0.5)Shareholders' equity, FY2024, at 2024-12-31−$456.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 25.0Shareholders' equity, Q1 FY2025, at 2025-03-31$25.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 120Shareholders' equity, Q2 FY2025, at 2025-06-30$119.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 107Shareholders' equity, Q3 FY2025, at 2025-09-30$107.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-269477.Report this figure | 99.0Shareholders' equity, FY2025, at 2025-12-31$99.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 320Shareholders' equity, Q1 FY2026, at 2026-03-31$319.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure | 302Shareholders' equity, Q2 FY2026, at 2026-06-30$302.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-337950.Report this figure |
Cash flow
| Line item | Unit | Q3 FY20232023-09-30 | Q4 FY20232023-12-31 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q4 FY20242024-12-31 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q4 FY20252025-12-31 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $m | (18.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$18.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123249. Derived: 9-month figure less the 6-month figure.Report this figure | (22.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$22.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-06, accession 0000950170-25-034575. Derived: 12-month figure less the 9-month figure.Report this figure | (26.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$26.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | (19.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$19.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0000950170-25-104991. Derived: 6-month figure less the 3-month figure.Report this figure | (20.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$20.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269477. Derived: 9-month figure less the 6-month figure.Report this figure | (19.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$19.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | (21.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$21.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | (15.8)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$15.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337950. Derived: 6-month figure less the 3-month figure.Report this figure | (15.5)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269477. Derived: 9-month figure less the 6-month figure.Report this figure | (23.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$23.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | (25.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$25.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | (18.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$18.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-337950. Derived: 6-month figure less the 3-month figure.Report this figure |
| Capital expenditure | $m | 0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123249. Derived: 9-month figure less the 6-month figure.Report this figure | 0.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$266.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-06, accession 0000950170-25-034575. Derived: 12-month figure less the 9-month figure.Report this figure | 0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$115.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0000950170-25-068511.Report this figure | 0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$96.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0000950170-25-104991. Derived: 6-month figure less the 3-month figure.Report this figure | 0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269477. Derived: 9-month figure less the 6-month figure.Report this figure | 0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$80.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 0.1Capital expenditure, Q1 FY2025, three months to 2025-03-31$119.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$27.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337950. Derived: 6-month figure less the 3-month figure.Report this figure | (0.1)Capital expenditure, Q3 FY2025, three months to 2025-09-30−$127.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269477. Derived: 9-month figure less the 6-month figure.Report this figure | 0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$201.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001193125-26-107146. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-211868.Report this figure | 0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001193125-26-337950. Derived: 6-month figure less the 3-month figure.Report this figure |
Shares
| Line item | Unit | Q3 FY20222022-09-30 | Q1 FY20232023-03-31 | Q2 FY20232023-06-30 | Q3 FY20232023-09-30 | Q1 FY20242024-03-31 | Q2 FY20242024-06-30 | Q3 FY20242024-09-30 | Q1 FY20252025-03-31 | Q2 FY20252025-06-30 | Q3 FY20252025-09-30 | Q1 FY20262026-03-31 | Q2 FY20262026-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 65.9 | 66.2 | 66.5 | 81.0 | 82.6 | 84.9 | 85.2 | 87.2 | 129 | 165 | 177 | 219 |
Shares outstanding: 217.90m at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. Listed shows no prices and gives no investment advice.